Jason Nguyen, MD
Ophthalmology · Oklahoma City, OKNPI 1679000749
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,408 of the $8,538 with a category attached, or 86.8%. It is spread thinly across 19 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Among ophthalmology clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $55.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- NEW World Medical,inc.$2K
- Bausch & Lomb Americas Inc.$2K
- AbbVie$1K
- Alcon$975
- Rxsight Inc$653
- Sight Sciences, Inc.$365
- plus $2K from 13 others
Across 6 payments — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$30K
What the payments were for
- Travel & lodging$1,10613%
- Food & beverage$7,40887%
- Entertainment$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| NEW World Medical,inc. | 18 | $1,849 |
| Bausch & Lomb Americas Inc. | 15 | $1,604 |
| AbbVie(2 entities) | 34 | $1,442 |
| Alcon | 32 | $975 |
| Rxsight Inc | 13 | $653 |
| Sight Sciences, Inc. | 6 | $365 |
| Harrow Eye, LLC | 3 | $260 |
| Tarsus Pharmaceuticals, Inc. | 2 | $208 |
| Novartis | 10 | $174 |
| Carl Zeiss Meditec USA, Inc. | 3 | $170 |
| Glaukos Corporation | 2 | $169 |
| Ocular Therapeutix, Inc. | 5 | $169 |
| Dompe US, Inc. | 2 | $146 |
| Oyster Point Pharma, Inc. | 4 | $115 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $88 |
| The Cameron-ehlen Group, Inc. | 1 | $81 |
| Optos, Inc. | 1 | $25 |
| Eyevance Pharmaceuticals LLC | 1 | $23 |
| Vantage Technology LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- enVista Aspire IOL$1,113
- TENEO$1,113
- STELLARIS ELITE$1,113
- Kahook Dual Blade$1,050
- Ahmed Glaucoma Valve$1,050
- Clearpath$745
- Streamline$745
- XEN GLAUCOMA TREATMENT SYSTEM$653
- Via360$607
- DURYSTA$451
- RXSIGHT CONTACT LENS$305
- RXSIGHT INJECTOR CARTRIDGE$305
- RXSIGHT INJECTOR HANDPIECE$305
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$305
- LIGHT ADJUSTABLE LENS (LAL)$305
- Streamline Surgical System$305
- OMNI(R) SURGICAL SYSTEM (US)$256
- VEVYE$242
- Rhopressa$236
- Rocklatan$236
How this compares
$8,538 in reported general payments places this provider in the 90th percentile of 183 ophthalmology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Oklahoma City
- Ronald RebenitschOklahoma City$141K
- Edward JonesOklahoma City$13K
- John BelardoOklahoma City$12K
- David KorberOklahoma City$11K
- Annie ChanOklahoma City$6K
- Lance ScottOklahoma City$5K
- Craig EckOklahoma City$5K
- Valerie LobodiakOklahoma City$4K
- Clifton FayOklahoma City$3K
- Evan AllanOklahoma City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.